ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.

ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.
复制标题

DOI:
10.1007/s10585-010-9337-9
复制
发表时间:
2010-10
影响因子:
4
通讯作者:
MacDonald, Tobey J.
MacDonald, Tobey J.
中科院分区:
医学3区
文献类型:
--
作者:
Yuan, Liangping;Santi, Mariarita;Rushing, Elisabeth J.;Cornelison, Robert;MacDonald, Tobey J.

文献摘要

参考文献

被引文献

相似文献

We previously identified that overexpression of the platelet-derived growth factor receptor (PDGFR) is associated with metastatic medulloblastoma (MB) and showed that PDGF treatment increases ERK activity and promotes MB cell migration. In this study, we investigated whether ERK regulates Rac1/Pak1 signaling and is critically linked to MB cell migration. Herein we demonstrate that PDGF-BB treatment of MB cells induces concomitant activation of PDGFRβ, MEK1/ERK, Rac1 and Pak1, but suppresses Rho activity, which together significantly promotes cell migration. Conversely, cells transfected with either PDGFRβ or Pak1 siRNA or treated with an inhibitor of Rac1 (NSC23766) or N-myristoyltransferase-1 (Tris-dipalladium) are unable to activate Rac1 or Pak1 in response to PDGF, and consequently, are unable to undergo PDGF-mediated cell migration. Furthermore, we also demonstrate that either chemical inhibition of MEK/ ERK (U0126) or stable downregulation of PDGFRβ by shRNA similarly results in the loss of PDGF-induced ERK phosphorylation and abolishes Rac1/Pak1 activation and cell migration in response to PDGF. However, specific depletion of Pak1 by siRNA has no effect on PDGF-induced ERK phosphorylation, indicating that in MB cells ERK signaling is Pak1-independent, but PDGF-induced migration is dependent on ERK-mediated activation of Pak1. Finally, using tissue microarrays, we detect phosphorylated Pak1 in 53% of medulloblastomas and show that immunopositivity is associated with unfavorable outcome. We conclude that Rac1/Pak1 signaling is critical to MB cell migration and is functionally dependent on PDGFRβ/ERK activity.
DOI: 10.1083/jcb.151.7.1549
发表时间: 2000-12-25
影响因子: 7.8
作者:
Berrier, A L;Mastrangelo, A M;Downward, J;Ginsberg, M;LaFlamme, S E
通讯作者: LaFlamme, S E
DOI: 10.1158/0008-5472.can-07-0986
发表时间: 2007-11-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Lee, Sok-Hyong;Kunz, Jeannette;Yu-Lee, Li-yuan
通讯作者: Yu-Lee, Li-yuan
DOI: 10.1677/erc-06-0036
发表时间: 2007-06-01
影响因子: 3.9
作者:
Engers, R.;Ziegler, S.;Gabbert, H. E.
通讯作者: Gabbert, H. E.
DOI: 10.1074/jbc.275.16.12041
发表时间: 2000-04-21
影响因子: 4.8
作者:
Adam, L;Vadlamudi, R;Kumar, R
通讯作者: Kumar, R
DOI: 10.1200/jco.2005.09.095
发表时间: 2005-10-20
影响因子: 45.3
作者:
Geyer, JR;Sposto, R;Shiminski-Maher, T
通讯作者: Shiminski-Maher, T